TY - CHAP AB - Abstract This chapter aims at providing an understanding of the research and devlopment (R&D) process in the pharmaceutical industry, by exploring the methodological challenges and approaches in the assessment of the determinants of innovation in the pharmaceutical industry. It (i) discusses possible methodological approaches to model occurrence of events; (ii) describes in detail competing risks duration models as the best methodological option in light of the nature of pharmaceutical R&D processes and data; (iii) concludes with an estimation strategy and overview of potential covariates that have been found to correlate with the likelihood of failure of R&D pharmaceutical projects. VL - 294 SN - 978-1-78714-541-2, 978-1-78714-542-9/0573-8555 DO - 10.1108/S0573-855520180000294010 UR - https://doi.org/10.1108/S0573-855520180000294010 AU - Barrenho Eliana AU - Miraldo Marisa PY - 2018 Y1 - 2018/01/01 TI - R&D Success in Pharmaceutical Markets: A Duration Model Approach T2 - Health Econometrics T3 - Contributions to Economic Analysis PB - Emerald Publishing Limited SP - 201 EP - 233 Y2 - 2024/03/28 ER -